Annals of internal medicine
-
Childhood cancer survivors treated with cardiotoxic therapies are recommended to have routine cardiac assessment every 1 to 5 years, but the long-term benefits are uncertain. ⋯ Current recommendations for cardiac assessment may reduce CHF incidence, but less frequent assessment may be preferable.
-
The findings of the Women's Health Initiative (WHI) estrogen plus progestin (E+P) trial led to a substantial reduction in use of combined hormone therapy (cHT) among postmenopausal women in the United States. The economic effect of this shift has not been evaluated relative to the trial's $260 million cost (2012 U.S. dollars). ⋯ National Heart, Lung, and Blood Institute.